CSGCX
Price
$43.61
Change
+$0.03 (+0.07%)
Updated
Jun 25 closing price
Net Assets
1.37B
RLBCX
Price
$35.92
Change
-$0.04 (-0.11%)
Updated
Jun 25 closing price
Net Assets
248.02B
Interact to see
Advertisement

CSGCX vs RLBCX

Header iconCSGCX vs RLBCX Comparison
Open Charts CSGCX vs RLBCXBanner chart's image
Calvert Balanced C
Price$43.61
Change+$0.03 (+0.07%)
VolumeN/A
Net Assets1.37B
American Funds American Balanced R3
Price$35.92
Change-$0.04 (-0.11%)
VolumeN/A
Net Assets248.02B
CSGCX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CSGCX vs. RLBCX commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSGCX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 248B vs. CSGCX (1.38B). RLBCX pays higher dividends than CSGCX: RLBCX (1.63) vs CSGCX (0.67). CSGCX was incepted earlier than RLBCX: CSGCX (31 years) vs RLBCX (23 years). CSGCX (1.66) is less costly to investors than RLBCX (0.89). CSGCX is a more actively managed with annual turnover of: 153.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than CSGCX: RLBCX (250) vs CSGCX (1000). RLBCX annual gain was more profitable for investors over the last year : 6.05 vs. CSGCX (3.88). RLBCX return over 5 years is better than : 39.81 vs. CSGCX (35.66).
CSGCXRLBCXCSGCX / RLBCX
Total Expense Ratio1.660.89187%
Annual Report Gross Expense Ratio1.660.89187%
Fund Existence31 years23 years-
Gain YTD2.6065.79645%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.38B248B1%
Annual Yield % from dividends0.671.6341%
Returns for 1 year3.886.0564%
Returns for 3 years30.9430.55101%
Returns for 5 years35.6639.8190%
Returns for 10 years39.1957.7468%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTRN30.650.29
+0.96%
Citi Trends
IT402.642.25
+0.56%
Gartner
NTLA9.56-0.01
-0.10%
Intellia Therapeutics
VRRM25.01-0.18
-0.71%
Verra Mobility Corp
GBIO0.36-0.01
-1.51%
Generation Bio Co